VIM and colorectal cancer: In colorectal cancer (CRC), the loss of PTPN23 leads to decreased expression of E-cadherin, along with upregulation of epithelial-mesenchymal transition (EMT) markers such as Vimentin and SNAIL, promoting cell migration [55].